Abstract
Candida albicans, the major human fungal pathogen, undergoes a reversible morphological transition from single yeast cells to pseudohyphal and hyphal filaments (elongated cells attached end-to-end). Because typical C. albicans infections contain a mixture of these morphologies it has, for many years, been difficult to assess the relative contribution of each form to virulence. In addition, the regulatory mechanisms that determine growth in pseudohyphal and hyphal morphologies are largely unknown. To address these questions we have generated a C. albicans strain that can be genetically manipulated to grow completely in the hyphal form under non-filament-inducing conditions in vitro. This was achieved by inducing high-level constitutive expression of UME6, a recently identified filament-specific transcriptional regulator of C. albicans hyphal extension. We show that high-level UME6 expression significantly increases hyphal formation and promotes virulence in a mouse model of systemic candidiasis. Our results strongly suggest that shifting the morphology of a C. albicans population toward the hyphal form, and/or increasing hyphal-specific gene expression, during the course of infection is sufficient to improve virulence potential. We also demonstrate that lower levels of UME6 expression specify growth largely in the pseudohyphal form and that increasing UME6 levels is sufficient to cause cells to gradually shift from pseudohyphal to hyphal morphology. In addition, we show that UME6 levels differentially induce the expression of several known filament-specific transcripts. These findings suggest that a common transcriptional regulatory mechanism functions to specify both pseudohyphal and hyphal morphologies in a dosage-dependent manner.
Keywords: filamentous growth, transcriptional regulation
Candida albicans is the most important human fungal pathogen because of its frequency of isolation and the amount of morbidity and mortality it causes. Although normally found as a commensal in the human gastrointestinal tract, C. albicans is responsible for a wide variety of mucosal infections such as oral and vaginal thrush. C. albicans also infects every organ and tissue in the human body (1–3). Approximately 70% of all women will experience at least one episode of vaginal candidiasis during their lifetime (4), and systemic candidiasis is now the fourth-leading cause of hospital-acquired bloodstream infections in the United States, with a mortality rate approaching 35% (5). AIDS patients, organ transplant recipients, cancer patients on chemotherapy, recipients of artificial joints and prosthetic devices, and other immunocompromised individuals are particularly susceptible to infection (for reviews see refs. 2, 3, and 6).
One property known to contribute to C. albicans virulence is the ability to undergo a morphological transition from yeast (single, oval budding cells) to filaments (elongated cells attached end-to-end) (for reviews see refs. 7 and 8). This transition is known to occur in response to a variety of inducing signals present in the host environment, including serum, body temperature (37 °C), neutral pH, amino acids, and certain human hormones (7–9). C. albicans filaments can be found in two distinct morphologies: pseudohyphae and hyphae. Pseudohyphal cells are highly branched, ellipsoidal in form, and have constrictions at cell junctions whereas hyphal cells are less branched, have parallel sides, and lack constrictions at the septa. Other differences include the way nuclear division occurs, the cell cycle, and the presence of a specialized structure, the Spitzenkörper, which is important for concentrating and delivering secretory vesicles to the tip of hyphal cells (1, 10). Because of the extensive phenotypic differences between hyphal and pseudohyphal cells it is generally believed that expression of different gene sets specifies each morphology, although definitive evidence is lacking.
Despite the fact that the phenotypes of C. albicans hyphal and pseudohyphal cells have been well-characterized, considerably less is known about the genetic determinants for growth in each form or how these forms differ at the molecular level. In addition, although considerable evidence suggests that the ability of C. albicans to undergo the transition from yeast to filaments is required for virulence (11, 12), the relative contribution of pseudohyphal and hyphal morphologies to virulence and the specific role that each morphology plays in this process has remained elusive because tissues infected with C. albicans typically contain a mixed population of yeast, pseudohyphae, and hyphae (1).
Here we report the generation of a C. albicans strain that can be genetically manipulated to grow completely in the hyphal morphology in the absence of filament-inducing conditions in vitro and to show significantly increased hyphal formation and extension during infection in vivo. This strain provides us with a powerful tool to address many of the questions described above, including the specific role of the C. albicans hyphal form in virulence and the regulatory mechanisms that function to determine C. albicans morphology.
Results
Constitutive High-Level UME6 Expression Is Sufficient to Drive Complete Hyphal Formation in the Absence of Filament-Inducing Conditions.
We have recently identified a filament-specific transcriptional regulator of C. albicans hyphal extension and virulence, UME6, which controls the level and duration of filament-specific gene expression in response to inducing conditions (13). To determine the effect of high-level UME6 expression on C. albicans morphology, one allele of UME6 was placed under control of a regulatable promoter consisting of the Escherichia coli tet operator [we chose not to regulate UME6 in a strain in which the other allele was absent because a homozygous ume6 deletion strain is attenuated for virulence whereas a strain expressing one functional copy of UME6 behaves nearly identical to a WT strain with respect to virulence (13)]. This experiment was carried out in a strain expressing high constitutive levels of an E. coli tet repressor–Saccharomyces cerevisiae Hap4 activation domain fusion protein (tetR-Hap4 AD) (Fig. 1A). In the absence of doxycycline (Dox, a tetracycline derivative), this fusion protein binds to the tet operator as a dimer and directs constitutive high levels of transcriptional activation. In the presence of Dox, dimerization is blocked, preventing DNA binding and effectively shutting off the transcription factor. This system has previously been used successfully by several groups to induce constitutive high-level gene expression in C. albicans both in vitro and during infection in vivo (12, 14).
Fig. 1.
High-level constitutive UME6 expression drives complete hyphal formation. (A) One UME6 allele was placed under control of the E. coli tet operator (tetO) in strain THE1 (14), which expresses an E. coli tet repressor–S. cerevisiae Hap4 activation domain fusion protein (tetR-HAP4 AD). In the absence of Dox (a tetracycline derivative) this fusion protein dimerizes at the tet operator and directs constitutive high-level transcriptional activation of UME6. In the presence of Dox, the fusion protein fails to dimerize and this allele of UME6 is no longer activated. (B) Northern analysis of UME6 and ACT1 (control) transcript levels in both THE1 (parent) and tetO-UME6 strains grown in YEPD medium (non-filament-inducing conditions) at 30 °C in the presence and absence of 40 μg/mL Dox. (C) Images of cells used to prepare RNA for the Northern in B and of colonies of the THE1 and tetO-UME6 strains grown in the presence and absence of 40 μg/mL Dox in YEPD medium at 30 °C for 2 days. (Scale bar: 10 μm.)
In the absence of Dox, the strain containing one allele of UME6 under control of the tet operator (tetO-UME6) showed a highly filamentous colony morphology when grown under non-filament-inducing conditions (YEPD at 30 °C) (Fig. 1C). These colonies were also highly adherent to the agar. Strikingly, microscopic examination of a liquid YEPD culture revealed that virtually all cells from this strain appeared to grow in hyphal form. In contrast, when the tetO-UME6 strain was grown in the presence of 40 μg/mL Dox, or when the parent strain (only expressing the tetR-Hap4 AD fusion protein) was grown in either the presence or the absence of Dox, cells were in the yeast form (Fig. 1C). Northern analysis confirmed that the UME6 transcript was expressed at high levels specifically in the tetO-UME6 strain grown in the absence of Dox (Fig. 1B). Similar results were obtained when these experiments were repeated with a 20 μg/mL Dox concentration.
To confirm that the extended filaments generated by constitutive high-level UME6 expression were indeed hyphae, cells of the tetO-UME6 strain grown in the absence of Dox were stained with DAPI, calcofluor white, and filipin (Fig. 2). DAPI staining indicated that each filament was comprised of multiple cells, each with its own nucleus (rather than one long extended cell). Calcofluor white staining showed that all cells in each filament were attached by true septal junctions (lacking constrictions). Finally, all cells stained positive for filipin at the filament tip; filipin has been shown to stain sterols that specifically concentrate at the tip of hyphal, but not pseudohyphal, cells (15). Taken together, our results indicate that high-level constitutive UME6 expression is sufficient to drive complete hyphal formation in the absence of filament-inducing conditions. We also note that in the absence of Dox the tetO-UME6 strain grew as complete hyphae in the presence of 10% serum at 37 °C, which is a strong filament-inducing condition (P.L.C. and D.K., unpublished observations).
Fig. 2.
Microscopic examination of filaments generated by high-level constitutive UME6 expression. The tetO-UME6 strain was grown in the absence of Dox as described in Fig. 1, and aliquots of cells were fixed, stained with 1 μg/mL DAPI or 10 μg/mL Calcofluor white, incubated for 10 min at room temperature, washed 3 times in 1× PBS, and analyzed by fluorescence microscopy. For filipin staining, cells were grown in a similar manner (but not fixed), stained with 8 μg/mL filipin for 20 min at room temperature, washed once with 1× PBS, and analyzed by fluorescence microscopy. (Scale bar: 10 μm.)
High-Level Constitutive UME6 Expression Is Sufficient to Promote Virulence in a Mouse Model of Systemic Candidiasis.
One advantage of the tetracycline-regulatable gene expression system described above is that it can be used to control gene expression during infection in a mouse model of systemic candidiasis by the addition or removal of Dox in the drinking water (12, 14). To determine the effect of constitutive high-level UME6 expression on virulence, 16 mice were each injected with the tetO-UME6 strain. Three days prior to infection, 8 of these mice were placed on drinking water containing Dox; the remaining 8 mice were placed on drinking water lacking Dox. Strikingly, we found that whereas only 3 mice placed on drinking water with Dox died after 30 days, nearly all of the mice on drinking water lacking Dox died by 11 days post-infection (Fig. 3A); we have also observed that virulence of a control strain that lacks the tet operator is not affected by the presence or absence of Dox (data not shown). These results strongly suggest that constitutive high-level UME6 expression promotes virulence in a mouse model of systemic candidiasis. It is important to note that increased virulence is observed relative to that of the tetO-UME6 strain in the presence of Dox, which expresses one functional copy of UME6. However, we have previously demonstrated that a strain expressing one functional copy of UME6 does not show a significant difference in virulence when compared with a WT strain (13).
Fig. 3.
High-level constitutive UME6 expression is sufficient to promote virulence and tissue invasion. (A) Sixteen female BALB/c mice (6–8 weeks old) were injected by tail vein with 6 × 105 CFUs of the tetO-UME6 strain grown in the presence of Dox. Three days prior to infection one group of mice (n = 8) was placed on drinking water containing 2 mg/mL Dox (+DOX) while a second group of mice (n = 8) was placed on drinking water lacking Dox (−DOX). Survival was monitored over the course of 30 days. A Kaplan–Meier test was performed to confirm that the difference in virulence between +DOX and −DOX groups is statistically significant (P ≤ 0.05). (B) Kidney tissues from mice infected with the tetO-UME6 strain (+DOX and −DOX) were fixed, sectioned, and stained with Grocot–Gomori methenamine silver to visualize fungal cells (“days” indicate postinfection time points); a typical kidney section from a mouse infected with a WT strain is shown as a reference. Fungal cells are indicated in black. (Scale bar: 10 μm.)
We also carried out histology studies to determine the effect of constitutive high-level UME6 expression on C. albicans morphology and tissue invasion during infection. Kidneys from mice infected with the tetO-UME6 strain were fixed, sectioned, and stained with Grocot–Gomori methenamine silver to visualize fungal cells (Fig. 3B). Interestingly, we observed significantly increased C. albicans hyphal formation, hyphal extension, and tissue invasion in kidneys from mice placed on drinking water lacking Dox. In contrast, kidneys of mice placed on drinking water containing Dox showed a more typical heterogeneous mixed population of yeast, pseudohyphae, and hyphae comparable to that observed in kidneys of mice infected with a WT strain (please note that although only one tetO-UME6 +Dox time point is shown in Fig. 3B, we have observed a similar morphological pattern at other postinfection time points). Importantly, constitutive high-level UME6 expression was sufficient to drive increased hyphal formation and extension generally over the course of the entire infection (Fig. 3B), suggesting that a morphological shift of the C. albicans population toward the hyphal morphology, and/or increased hyphal-specific gene expression, plays a specific important role in promoting virulence.
It is important to note that inoculations for this experiment were carried out using yeast form cells that had been grown and washed in the presence of Dox. Because yeast cells have been shown to play an important role in dissemination and, under physiological conditions, are more likely to be the infectious inocula from sources such as biofilms in the gastrointestinal tract or other mucosal surfaces, we believe that our experiment more closely parallels an actual infection. We did not carry out our inoculations using complete hyphae because we found that it is impossible to accurately count these cells and obtain a correct inoculum size [since hyphal cells are extremely clumpy and, unlike a previous study, which involved injection of constitutively pseudohyphal cells (16), septal constrictions were absent].
Expression Levels of UME6 Are Sufficient to Determine C. albicans Morphology.
The experiments above describe the effect of constitutive high-level UME6 expression on C. albicans morphology. To determine the effects of low and intermediate levels of UME6 we grew cells of the tetO-UME6 strain under non-filament-inducing conditions (YEPD medium at 30 °C) at various Dox concentrations. As shown in Fig. 4A, UME6 expression first becomes apparent at 0.2 μg/mL Dox and gradually rises with decreasing Dox concentration. Interestingly, low UME6 expression levels (at 0.2 and 0.1 μg/mL Dox) generated a population in which the large majority (≈80%) of C. albicans cells grew in the pseudohyphal form (Fig. 4B); most of the remaining ≈20% of cells grew as yeast. As the Dox concentration decreased and UME6 levels rose, we observed that a large fraction of the population began to grow in the hyphal form and that the ratio of cells in hyphal vs. pseudohyphal morphologies increased (several hybrid hyphal–pseudohyphal filaments were also apparent). Finally, as previously observed, in the absence of Dox cells grew completely in the hyphal form. These results indicate that, in the absence of filament-inducing conditions, expression levels of UME6 alone are sufficient to determine C. albicans morphology.
Fig. 4.
UME6 expression levels determine C. albicans morphology and cause induction of filament-specific genes in the absence of filament-inducing conditions. (A) The tetO-UME6 strain was grown under non-filament-inducing conditions (YEPD medium at 30 °C) in the presence of the indicated concentrations of Dox. Cells were harvested for RNA preparation, and Northern analysis was carried out using probes to the indicated transcripts (ACT1 and rRNA are shown as loading controls). (B) Aliquots of cells used in A were fixed in formaldehyde, washed twice in 1× PBS, and visualized by DIC optics. Numbers indicate Dox concentration (μg/mL). (C) The tetO-UME6 strain was grown in YEPD medium at 30 °C (non-filament-inducing conditions) in the presence of 1 μg/mL Dox, washed twice in ddH2O, and returned to fresh YEPD medium (prewarmed to 30 °C) in the absence of Dox. (D) The tetO-UME6 strain was grown in YEPD medium at 30 °C in the absence of Dox, and Dox was added to a concentration of 40 μg/mL. For C and D, aliquots of cells were harvested at the indicated time points, fixed with formaldehyde, washed twice with 1× PBS, and visualized by DIC optics. (Scale bars: 10 μm.)
Next we sought to determine the effect of increasing UME6 levels on morphology of the tetO-UME6 strain over a time course. As shown in Fig. 4C, removal of Dox from a culture of the tetO-UME6 strain grown in the presence of Dox causes cells to gradually shift morphology over time. Cells initially grew as yeast, and pseudohyphae began to form as early as 1 h after Dox removal; the majority of cells grew as pseudohyphae by the 3-h time point. As the time course proceeded, cells gradually shifted to a hyphal morphology, and by the 9-h time point nearly all of the cells were in the hyphal form. Interestingly, although many cells formed germ tubes at early time points, the subapical cells of these germ tubes also appeared to shift to the hyphal form at later time points, generating pure hyphal filaments. To determine the effect of shutting off UME6 on the morphology of hyphal filaments, the tetO-UME6 strain was grown in the absence of Dox (generating a complete hyphal population) and Dox was added to a concentration of 40 μg/mL (Fig. 4D). By 1 h after Dox addition, filaments showed constrictions at their septa. At the 3-h time point, the majority of new cells growing off the filaments appeared as pseudohyphae, and by the 7-h time point many cells surrounding these filaments were in yeast form. At 9 h after Dox addition the large majority of cells grew as dispersed yeast (similar results were obtained in a time course experiment involving the addition of 20 μg/mL Dox). These results are consistent with our previous findings (Fig. 4B) and suggest that UME6 levels are sufficient to cause C. albicans cells to reversibly alter morphology from yeast to a majority pseudohyphae to hyphae. It is important to note here that, as in our previous experiment (Fig. 4B), at no point did we observe a complete pseudohyphal population; rather, the large majority of cells at intermediate time points of these experiments appeared to grow in pseudohyphal form.
Expression Levels of UME6 Are Sufficient to Cause Induction of Filament-Specific Transcripts in the Absence of Filament-Inducing Conditions.
Because expression of UME6 has a significant effect on C. albicans morphology and this gene encodes a transcriptional regulator (13), we next wanted to examine the effect of UME6 levels on a variety of filament-specific transcripts. Northern analysis, using probes to several known filament-specific genes, was carried out on total RNA prepared from tetO-UME6 cells grown at various Dox concentrations or in the absence of Dox. As shown in Fig. 4A, all of these transcripts were significantly induced in the presence of constitutive high levels of UME6 expression (in the absence of Dox). Interestingly, only a fraction of the filament-specific transcripts (ECE1, PHR1, and HGC1) were mildly induced in response to initial low-level UME6 expression at 0.2 μg/mL Dox (at this Dox concentration cells grow predominantly in the pseudohyphal form). As UME6 levels rose, there was an increase in both the number of filament-specific transcripts induced as well as their level of induction. These results indicate that UME6 levels can differentially induce the expression of a variety of filament-specific transcripts in the absence of filament-inducing conditions. These findings are consistent with our previous observations that UME6 expression levels determine C. albicans morphology (Fig. 4 B–D) and that UME6 controls the level and duration of filament-specific gene expression in response to inducing conditions (13).
Discussion
Role of the C. albicans Hyphal Morphology in Virulence.
Because most of the major human systemic fungal pathogens are dimorphic, the role of morphology in virulence has long been an area of intense interest in fungal pathogenesis. Because typical C. albicans infections contain a mixture of yeast, pseudohyphae, and hyphae (1) it has, for many years, been difficult to assess the relative contribution of each morphology to virulence. Although more recent compelling evidence suggests that the yeast form is highly attenuated for virulence and that the yeast-to-filament transition is required (11, 12), the precise role of pseudohyphal and hyphal morphologies has remained elusive. Because our tetO-UME6 strain can be genetically manipulated to grow exclusively in the hyphal form in vitro and to show a significant increase in hyphal formation and extension during the course of an infection in vivo, we are now in a better position to at least partially address this question. Our results are significant because they suggest that shifting the morphology of a C. albicans population toward the hyphal form over the course of a systemic infection, and/or increasing hyphal-specific gene expression, is sufficient to improve virulence potential. Although constitutive high-level UME6 expression does not drive complete hyphal formation during infection, these findings provide the most direct demonstration to date that the C. albicans hyphal morphology (and hyphal-associated gene expression) plays a specific important role in promoting virulence in the host once an infection has been established. Our findings are also consistent with previous studies that have implicated the C. albicans hyphal form in a variety of virulence-related processes, including the invasion of epithelial cell layers, thigmotropism, breaching of endothelial cells, and lysis of macrophages and neutrophils after phagocytosis (11, 17). Given that previous studies, using clinical isolates, have shown a correlation between increased hyphal formation and a higher level of invasion of a tissue-engineered oral epithelial cell layer (18), we expect that in the absence of Dox our tetO-UME6 strain would promote mucosal C. albicans infections as well.
It is important to bear in mind that our study, like most previous studies that have examined the relationship between C. albicans morphology and virulence, involves the use of a transcriptional regulator. As such, we cannot exclude the possibility that the observed virulence effects are due to altered expression of target genes that are not necessarily involved in filamentation per se but rather some other process [genes involved in a variety of virulence processes are known to be induced during filamentation (19, 20)]. However, one important study that did not involve the use of transcriptional regulators has provided very compelling evidence for a direct link between filamentation and virulence. In this study, Zheng et al. (21) demonstrated that deletion of HGC1, a filament-induced cyclin-related gene important for septin phosphorylation, resulted in reduced hyphal extension and highly attenuated virulence. Interestingly, our work shows that UME6, which is also expressed only under filament-inducing conditions, causes induction of HGC1.
Expression Levels of a Filament-Specific Transcriptional Regulator Are Sufficient to Determine C. albicans Morphology.
Despite the fact that C. albicans pseudohyphal and hyphal morphologies have been phenotypically well-characterized, little is known about the regulatory mechanisms that determine growth in each form. Our finding that expression levels of UME6 are sufficient to specify growth in both the pseudohyphal and hyphal forms is significant in that it challenges the current paradigm that these morphologies represent genetically distinct developmental states (10) and suggests that the transition between C. albicans morphologies is controlled by a common transcriptional regulatory mechanism in a dosage-dependent manner.
Our results suggest a model in which UME6 levels determine C. albicans morphology by controlling the expression levels of overlapping subsets of genes in the C. albicans filamentous growth program (Fig. 5). At low UME6 levels a particular subset of filament-specific genes is expressed that specifies growth largely in the pseudohyphal form. As UME6 levels rise, this same set of genes is expressed at a higher level and additional subset(s) of filament-specific genes are also expressed at increasing levels, causing cells to grow in the hyphal morphology. This model is supported by several lines of evidence: (i) Only a fraction of filament-specific genes tested showed mild induction at a UME6 level that specifies largely pseudohyphal growth, whereas all filament-specific genes tested showed highly elevated expression in response to a UME6 level that specifies a complete hyphal morphology; these effects could be explained by differences in Ume6 binding site affinity, the number of Ume6 binding sites per target promoter, and/or indirect regulation. (ii) We have previously observed that UME6 promotes hyphal filament extension in response to serum at 37 °C by maintaining high-level expression of genes in the C. albicans filamentous growth program (13). (iii) Previous studies have identified specialized structures (e.g., the Spitzenkörper and true septa) that are specifically present in hyphal but not pseudohyphal cells (10, 22); in contrast, excluding differences in cell shape, no specialized pseudohyphal-specific structures have been identified to date. These observations suggest that additional filament-specific genes are expressed only in hyphal (not pseudohyphal) cells. Finally, we cannot exclude the possibility of alternative models involving the expression of pseudohyphal-specific gene set(s) or models in which the expression level of filament-specific genes does not affect the transition between morphological forms. To address these models more directly, we are currently carrying out DNA microarray analysis to examine the effect of UME6 levels on expression of the complete set of genes in the C. albicans filamentous growth program.
Fig. 5.
A possible mechanism by which Ume6 expression levels determine C. albicans morphology. When Ume6 is not expressed, the filamentous growth program is not induced and C. albicans cells grow as yeast. At lower Ume6 levels, a subset of filament-specific genes (Gene set A) is activated, causing the majority of cells to grow as pseudohyphae. As Ume6 levels rise, the first set of genes is expressed at higher levels and additional gene set(s) in the filamentous growth program are also expressed at increasing levels. As a consequence, cells are directed to grow in the hyphal form, promoting tissue invasion and virulence. Please note that in the presence of filament-inducing conditions additional regulators are also likely to play a role in determining C. albicans morphology by contributing to increased expression of overlapping subsets of filament-specific genes. In addition, alternative models that involve the expression of pseudohyphal-specific gene sets cannot be excluded.
Interestingly, our observation that activation of UME6 over a time course causes cells to transition from a population of yeast to majority pseudohyphae and finally to complete hyphae suggests that the C. albicans pseudohyphal form may in some sense function as an “intermediate” morphology. Whereas most dimorphic fungal pathogens are known to transition between yeast and hyphal forms, the pseudohyphal morphology appears, for the most part, to be unique to C. albicans (1, 23). Given that C. albicans is one of the most highly evolved fungal pathogens with respect to colonization and survival within the mammalian host, our results raise intriguing questions regarding the evolutionary advantage that is conferred by such an intermediate morphology.
In addition to challenging the current paradigm that pseudohyphal and hyphal morphologies represent genetically distinct developmental states (10), these studies are significant in that they provide important information about the specific role of the C. albicans hyphal form in virulence as well as the mechanisms that function to determine C. albicans morphology. Ultimately, a more comprehensive understanding of these regulatory mechanisms will allow us to gain broader insight into the relationship between fungal morphology and virulence.
Materials and Methods
Strains and DNA Constructions.
The strains used in this study were THE1 (14), which constitutively expresses an E. coli tet-repressor–S. cerevisiae Hap4 activation domain fusion protein, and MBY38, the tetO-UME6 strain. To generate MBY38 we constructed a plasmid that would allow us to integrate the E. coli tet operator immediately upstream of one allele of UME6. This was accomplished by cloning a PCR product [primers 1 and 2, see supporting information (SI) Table S1 for a complete listing of primers used in this study] containing a UME6 promoter fragment (−651 to −123 relative to the UME6 start ATG) into plasmid p97CAU1 (14) digested with KpnI and XhoI. A second PCR product (primers 3 and 4) spanning a region from −47 to +444 (relative to the UME6 start ATG) was next cloned into the resulting plasmid digested with SpeI and SacII to generate p97CAU1-UME6-OEx. Finally, a 3-kb KpnI-SacII fragment containing the URA3 marker, tetO operator, and UME6 flanks was excised from p97CAU1-UME6-OEx and used to transform THE1 to generate MBY38 (the tetO-UME6 strain). This integration event was confirmed by whole-cell PCR using primers flanking the integration sites. The WT strain (DK318) used in Fig. 3 has been described previously (13).
Media and Growth Conditions.
Strains were routinely grown under non-filament-inducing conditions (YEPD medium at 30 °C) in the presence or absence of 40 μg/mL Dox. See SI Text for a more detailed description of growth conditions used in each experiment.
RNA Preparation and Analysis.
Total RNA was prepared by the hot acid phenol method (24). Probe preparation and Northern analysis (using 3 μg of total RNA from each sample) were carried out as described previously (13) (see Table S1 for a listing of primers used for each probe). Blots were scanned by using a phosphoimager and visualized with Imagequant 2.0 software.
Virulence Experiments and Histology.
The tetO-UME6 strain (MBY38) was grown overnight in YEPD medium in the presence of 20 μg/mL Dox at 25 °C, and cells were spun down and washed twice in sterile pyrogen-free saline containing 20 μg/mL Dox and once in sterile pyrogen-free saline containing 10 μg/mL Dox. Cells were counted by using a hemocytometer and diluted appropriately, and 200 μL of cell suspension was injected by lateral tail vein into individual 6- to 8-week-old BALB/c mice that were placed on drinking water containing 5% sucrose in the presence or absence of 2 mg/mL Dox (8 mice per group) 3 days prior to infection. Plate counts were carried out to determine the number and viability of cells in the inoculum. Mice were monitored for survival for 30 days after infection (moribund animals were euthanized and recorded as dying on the following day). The Kaplan–Meier log rank test was used to determine the statistical difference between +Dox and −Dox groups. This analysis was performed by using Prism and GraphPad software.
One kidney was removed from each deceased animal at the time of death for histology studies. Kidneys were fixed in 10% buffered formalin and embedded in paraffin. Thin slices of tissue were sectioned and stained with Grocot–Gomori methenamine silver and visualized by light microscopy.
Supplementary Material
Acknowledgments.
We thank Brian Wickes for reagents, useful advice, and suggestions during the course of experiments as well as for critical reading of the manuscript. We also thank members of the San Antonio Center for Medical Mycology for fruitful discussions. We are grateful to Hironobu Nakayama and Mikio Arisawa (Nippon Roche Research Center, Kamakura, Japan) for providing materials that allowed us to construct the tetO-UME6 strain. This work was supported by a COSTAR fellowship (National Institute of Dental and Craniofacial Research Grant DE14318) to P.L.C., American Heart Association Beginning Grant-in-Aid 0865242F, a University of Texas Health Science Center at San Antonio Executive Research Committee New Investigator Award (to D.K.), and National Institute of Allergy and Infectious Diseases Grant RO1AI064562 (to J.L.L.-R.).
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission. A.M. is a guest editor invited by the Editorial Board.
See Commentary on page 351.
This article contains supporting information online at www.pnas.org/cgi/content/full/0804061106/DCSupplemental.
References
- 1.Odds FC. Candida and Candidosis. London: Baillière Tindall; 1988. [DOI] [PubMed] [Google Scholar]
- 2.Dupont PF. Candida albicans, the opportunist. A cellular and molecular perspective. J Am Podiatr Med Assoc. 1995;85:104–115. doi: 10.7547/87507315-85-2-104. [DOI] [PubMed] [Google Scholar]
- 3.Weig M, Gross U, Muhlschlegel F. Clinical aspects and pathogenesis of Candida infection. Trends Microbiol. 1998;6:468–470. doi: 10.1016/s0966-842x(98)01407-3. [DOI] [PubMed] [Google Scholar]
- 4.Fidel PL, Jr, Vazquez JA, Sobel JD. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12:80–96. doi: 10.1128/cmr.12.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Edmond MB, et al. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis. 1999;29:239–244. doi: 10.1086/520192. [DOI] [PubMed] [Google Scholar]
- 6.Shepherd MG, Poulter RT, Sullivan PA. Candida albicans: Biology, genetics, and pathogenicity. Annu Rev Microbiol. 1985;39:579–614. doi: 10.1146/annurev.mi.39.100185.003051. [DOI] [PubMed] [Google Scholar]
- 7.Brown AJ. Morphogenetic signaling pathways in Candida albicans. In: Calderone RA, editor. Candida and Cadidiasis. Washington, DC: Am Soc Microbiol; 2002. pp. 67–86. [Google Scholar]
- 8.Mitchell AP. Dimorphism and virulence in Candida albicans. Curr Opin Microbiol. 1998;1:687–692. doi: 10.1016/s1369-5274(98)80116-1. [DOI] [PubMed] [Google Scholar]
- 9.Ernst JF. Transcription factors in Candida albicans—Environmental control of morphogenesis. Microbiology. 2000;146:1763–1774. doi: 10.1099/00221287-146-8-1763. [DOI] [PubMed] [Google Scholar]
- 10.Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12:317–324. doi: 10.1016/j.tim.2004.05.008. [DOI] [PubMed] [Google Scholar]
- 11.Lo HJ, et al. Nonfilamentous C. albicans mutants are avirulent. Cell. 1997;90:939–949. doi: 10.1016/s0092-8674(00)80358-x. [DOI] [PubMed] [Google Scholar]
- 12.Saville SP, Lazzell AL, Monteagudo C, López-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryotic Cell. 2003;2:1053–1060. doi: 10.1128/EC.2.5.1053-1060.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Banerjee M, et al. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell. 2008;19:1354–1365. doi: 10.1091/mbc.E07-11-1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nakayama H, et al. Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans. Infect Immun. 2000;68:6712–6719. doi: 10.1128/iai.68.12.6712-6719.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Martin SW, Konopka JB. Lipid raft polarization contributes to hyphal growth in Candida albicans. Eukaryotic Cell. 2004;3:675–684. doi: 10.1128/EC.3.3.675-684.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Braun BR, Head WS, Wang MX, Johnson AD. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics. 2000;156:31–44. doi: 10.1093/genetics/156.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol. 2005;7:1546–1554. doi: 10.1111/j.1462-5822.2005.00616.x. [DOI] [PubMed] [Google Scholar]
- 18.Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol. 2004;19:293–296. doi: 10.1111/j.1399-302X.2004.00155.x. [DOI] [PubMed] [Google Scholar]
- 19.Kadosh D, Johnson AD. Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: A genome-wide analysis. Mol Biol Cell. 2005;16:2903–2912. doi: 10.1091/mbc.E05-01-0073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nantel A, et al. Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol Biol Cell. 2002;13:3452–3465. doi: 10.1091/mbc.E02-05-0272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zheng X, Wang Y, Wang Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 2004;23:1845–1856. doi: 10.1038/sj.emboj.7600195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Crampin H, et al. Candida albicans hyphae have a Spitzenkörper that is distinct from the polarisome found in yeast and pseudohyphae. J Cell Sci. 2005;118:2935–2947. doi: 10.1242/jcs.02414. [DOI] [PubMed] [Google Scholar]
- 23.Collier L, Balons A, Sussman M. Microbiology and Microbial Infections. New York: Oxford Univ Press; 1998. [Google Scholar]
- 24.Ausubel FM, et al. Current Protocols in Molecular Biology. New York: Greene and Wiley-Interscience; 1992. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





